CTLA4 and neoplasm: By contrast, PD‐1/CTLA‐4 dual blockade neither restored CD4+ T cell infiltration nor enhanced IFN‐γ and Granzyme B production (Figure 7H–J), consistent with its limited anti‐tumour activity.